{
    "title": "109_hr3423",
    "content": "The Act may be cited as the \"Medical Device User Fee Stabilization Act of 2005\" and includes amendments to the Federal Food, Drug, and Cosmetic Act. The Federal Food, Drug, and Cosmetic Act is amended regarding device user fees, specifically in subsections (b) and (c) to adjust annual fee setting and fee publication processes. The Federal Food, Drug, and Cosmetic Act is amended to adjust device user fees for fiscal years 2006 and 2007, allowing the Secretary to use unobligated carryover balances from previous years to ensure fee revenues are sufficient. The Secretary must notify specific committees when anticipating fund use. Definitions for \"small business\" are clarified in relation to gross receipts. In subsection (e)(2)(A) and (g)(1), the amounts are increased from $30,000,000 to $100,000,000. Performance goals for fiscal year 2005 are specified based on appropriated funds. For fiscal year 2005, if the appropriated amount is more than 1% less than the amount under clause (i), specific provisions apply. For fiscal year 2005, the appropriated amount is more than 1% less than the amount under clause (i), specific provisions apply, including striking \"2003 through\" and inserting \"2005 and\", and inserting \"more than 1 percent\" after \"years, is\". In subsection (h)(3), amendments are made to subparagraphs (C), (D), and (E) for fiscal years 2006 and 2007. Section 103 of the Medical Device User Fee and Modernization Act of 2002 is also amended regarding annual reports. For fiscal years 2006 and 2007, the report under subsection (a)(2) must include information on different types of applications, fees paid by businesses with varying gross receipts, and a certification by the Secretary on the appropriation of funds for FDA expenses related to device functions. The Federal Food, Drug, and Cosmetic Act is amended to specify requirements for reprocessed single-use devices regarding manufacturer identification. The Federal Food, Drug, and Cosmetic Act is amended to specify requirements for reprocessed single-use devices regarding manufacturer identification, including guidance on labeling and manufacturer identification by the Secretary of Health and Human Services within 180 days of enactment. The effective date for Section 502(u) of the Federal Food, Drug, and Cosmetic Act is specified in relation to devices described under paragraph (1) of the section, with a 12-month timeline after the enactment of the Medical Device User Fee Stabilization Act of 2005 or when the original device is labeled with manufacturer information. The effective date for Section 502(u) of the Federal Food, Drug, and Cosmetic Act is specified for devices reprocessed and introduced in interstate commerce, with a 12-month timeline after the enactment of the Medical Device User Fee Stabilization Act of 2005 or when the original device is labeled with manufacturer information. The curr_chunk is about the roles of the Speaker of the House of Representatives and the Vice President of the United States as President of the Senate."
}